Related Experiment Video
Updated: Aug 13, 2026
03:19
Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Carnitine palmitoyltransferase deficiency in pregnancy
Patrick S Ramsey1, Joseph R Biggio
1Center for Research in Women's Health, University of Alabama at Birmingham, Department of Obstetrics and Gynecology, Birmingham, Alabama 35249-7333, USA. ramsey_patrick@hotmail.com
Summary
Carnitine palmitoyltransferase (CPT) deficiencies, a common inherited metabolic disorder, can cause muscle breakdown. This case highlights successful management of CPT II deficiency during pregnancy.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Carnitine palmitoyltransferase (CPT) deficiencies are inherited metabolic disorders affecting fatty acid oxidation.
- These conditions commonly lead to hypoglycemia-induced rhabdomyolysis (muscle breakdown).
- Limited data exists on managing CPT deficiencies during pregnancy.
Observation:
- A pregnant woman with CPT deficiency type II was managed.
- The case involved careful monitoring and intervention during gestation.
Findings:
- Successful management of CPT deficiency type II was achieved throughout the pregnancy.
- The patient's condition was stabilized, preventing complications.
Implications:
- This case provides valuable insights into managing CPT deficiencies in pregnant individuals.
- It suggests that with appropriate care, CPT deficiencies can be managed effectively during pregnancy.
- Further research is warranted to establish best practices for this patient population.
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:28Overview of Fatty Acid Metabolism
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...